Last reviewed · How we verify
heparinized saline priming group
Heparinized saline serves as a priming solution to prevent blood clotting during extracorporeal circulation.
Heparinized saline serves as a priming solution to prevent blood clotting during extracorporeal circulation. Used for Cardiac surgery.
At a glance
| Generic name | heparinized saline priming group |
|---|---|
| Sponsor | Seoul National University Hospital |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
Heparin, an anticoagulant, is added to saline solution to prevent the formation of blood clots in the extracorporeal circuit during cardiac surgery. This is crucial to maintain blood flow and prevent complications.
Approved indications
- Cardiac surgery
Common side effects
- Bleeding
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- heparinized saline priming group CI brief — competitive landscape report
- heparinized saline priming group updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI